Reports
Reports
The global haematology analyser and reagent market is expected to grow in the forecast period of 2023-2028 at a CAGR of 6%.
As healthcare facilities become increasingly modern on a global scale, the demand for advanced haematology technology is rising. This is due to its staple role in many forms of healthcare and diagnoses. Automated haematology analysers are becoming more common among commercial testing and hospital laboratories where high throughput is required. The surge in demand for analysers based on flow cytometry – counting a single file of cells passing through a laser detector – and other more recent technologies are driving the expansion of the industry. The increase in health consciousness and disease awareness is causing more people to take regular blood tests and donate blood. This is leading to higher requirements for point-of-care testing, which involves testing samples and providing results on-the-spot to patients/donors, thus supporting the growth of the haematology analyser industry and the reagents they require.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Haematology is a branch of medicine concerned with the treatment and prevention of blood-related diseases. These diseases may affect the production of blood cells, bone marrow, platelets, and others. In order to study these blood components, specialised instruments known as haematology analysers are required that can quantify the blood components present in a sample. Haematology reagents are used with analysers for counting blood cells.
The major products of haematology analysers and reagents are:
These can each be further divided into their types– instruments and reagents and consumables.
The market can be broadly categorised on the basis of its usage types into:
By price range, the market is broken down as:
The global haematology market is segregated based on application as:
The end-uses of the market include:
The EMR report looks into the regional markets of global haematology analyser and reagent market like North America, Europe, the Asia Pacific, Latin America and the Middle East and Africa.
The increase in haematological disorders and the ability to detect a variety of diseases and illnesses via blood-sample testing has led to the rising demand for high-throughput testing laboratories. This is applicable to commercial service providers and hospital laboratories that need to automate the entire workflow in order to test as many samples as possible, leading to a growth in the haematology analyser and reagent industry.
Haematology analysers and reagents are expected to see high demand during the COVID-19 pandemic due to their ability to sort patients infected with the virus based on blood parameters such as viscosity. Leukaemia, a type of blood cancer, is becoming increasingly prevalent, with an estimated 300,000 additional cases globally every year. Haematology is critical in the treatment of this disease, and efforts to curb its prevalence will lead to the increased demand for haematology analyser and reagent. However, the stringent government regulatory policies in this market can act as a barrier to new entrants and impair the growth of the industry.
The report presents a detailed analysis of the following key players in the global haematology analyser and reagent market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Usage Type, Price Range, Application, End Use, Region |
Breakup by Product | Haematology, Haemostasis, Immunohaematology |
Breakup by Usage Type | Standalone, Point-Of-Care |
Breakup by Price Range | Low Range, Mid-Range, High Range |
Breakup by Application | Haemorrhagic Conditions, Infection-Related Conditions, Immune System-Related Conditions, Blood Cancer, Anaemia, Others |
Breakup by End Use | Commercial Service Providers, Hospital Laboratories, Research and Academic Institutes, Others |
Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
Companies Covered | Abbott Laboratories, Beckman Coulter, Inc., HORIBA Ltd, Siemens Healthcare Private Limited, Nihon Kohden Corporation, Sysmex America, Inc., Others |
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Haematology Analyser and Reagent Market Analysis
8.1 Key Industry Highlights
8.2 Global Haematology Analyser and Reagent Historical Market (2018-2022)
8.3 Global Haematology Analyser and Reagent Market Forecast (2023-2028)
8.4 Global Haematology Analyser and Reagent Market by Product
8.4.1 Haematology
8.4.1.1 Historical Trend (2018-2022)
8.4.1.2 Forecast Trend (2023-2028)
8.4.1.3 Breakup by Type
8.4.1.3.1 Reagents and Consumables
8.4.1.3.1.1 Historical Trend (2018-2022)
8.4.1.3.1.2 Forecast Trend (2023-2028)
8.4.1.3.2 Instruments
8.4.1.3.2.1 Historical Trend (2018-2022)
8.4.1.3.2.2 Forecast Trend (2023-2028)
8.4.2 Haemostasis
8.4.2.1 Historical Trend (2018-2022)
8.4.2.2 Forecast Trend (2023-2028)
8.4.2.3 Breakup by Type
8.4.2.3.1 Reagents and Consumables
8.4.2.3.1.1 Historical Trend (2018-2022)
8.4.2.3.1.2 Forecast Trend (2023-2028)
8.4.2.3.2 Instruments
8.4.2.3.2.1 Historical Trend (2018-2022)
8.4.2.3.2.2 Forecast Trend (2023-2028)
8.4.3 Immunohaematology
8.4.3.1 Historical Trend (2018-2022)
8.4.3.2 Forecast Trend (2023-2028)
8.4.3.3 Breakup by Type
8.4.3.3.1 Reagents and Consumables
8.4.3.3.1.1 Historical Trend (2018-2022)
8.4.3.3.1.2 Forecast Trend (2023-2028)
8.4.3.3.2 Instruments
8.4.3.3.2.1 Historical Trend (2018-2022)
8.4.3.3.2.2 Forecast Trend (2023-2028)
8.5 Global Haematology Analyser and Reagent Market by Usage Type
8.5.1 Standalone
8.5.1.1 Historical Trend (2018-2022)
8.5.1.2 Forecast Trend (2023-2028)
8.5.2 Point-Of-Care
8.5.2.1 Historical Trend (2018-2022)
8.5.2.2 Forecast Trend (2023-2028)
8.6 Global Haematology Analyser and Reagent Market by Price Range
8.6.1 Low Range
8.6.1.1 Historical Trend (2018-2022)
8.6.1.2 Forecast Trend (2023-2028)
8.6.2 Mid-Range
8.6.2.1 Historical Trend (2018-2022)
8.6.2.2 Forecast Trend (2023-2028)
8.6.3 High Range
8.6.3.1 Historical Trend (2018-2022)
8.6.3.2 Forecast Trend (2023-2028)
8.7 Global Haematology Analyser and Reagent Market by Application
8.7.1 Haemorrhagic Conditions
8.7.1.1 Historical Trend (2018-2022)
8.7.1.2 Forecast Trend (2023-2028)
8.7.2 Infection-Related Conditions
8.7.2.1 Historical Trend (2018-2022)
8.7.2.2 Forecast Trend (2023-2028)
8.7.3 Immune System-Related Conditions
8.7.3.1 Historical Trend (2018-2022)
8.7.3.2 Forecast Trend (2023-2028)
8.7.4 Blood Cancer
8.7.4.1 Historical Trend (2018-2022)
8.7.4.2 Forecast Trend (2023-2028)
8.7.5 Anaemia
8.7.5.1 Historical Trend (2018-2022)
8.7.5.2 Forecast Trend (2023-2028)
8.7.6 Others
8.8 Global Haematology Analyser and Reagent Market by End Use
8.8.1 Commercial Service Providers
8.8.1.1 Historical Trend (2018-2022)
8.8.1.2 Forecast Trend (2023-2028)
8.8.2 Hospital Laboratories
8.8.2.1 Historical Trend (2018-2022)
8.8.2.2 Forecast Trend (2023-2028)
8.8.3 Research and Academic Institutes
8.8.3.1 Historical Trend (2018-2022)
8.8.3.2 Forecast Trend (2023-2028)
8.8.4 Others
8.9 Global Haematology Analyser and Reagent Market by Region
8.9.1 North America
8.9.1.1 Historical Trend (2018-2022)
8.9.1.2 Forecast Trend (2023-2028)
8.9.2 Europe
8.9.2.1 Historical Trend (2018-2022)
8.9.2.2 Forecast Trend (2023-2028)
8.9.3 Asia Pacific
8.9.3.1 Historical Trend (2018-2022)
8.9.3.2 Forecast Trend (2023-2028)
8.9.4 Latin America
8.9.4.1 Historical Trend (2018-2022)
8.9.4.2 Forecast Trend (2023-2028)
8.9.5 Middle East and Africa
8.9.5.1 Historical Trend (2018-2022)
8.9.5.2 Forecast Trend (2023-2028)
9 North America Haematology Analyser and Reagent Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
10 Europe Haematology Analyser and Reagent Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2022)
10.1.2 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Historical Trend (2018-2022)
10.2.2 Forecast Trend (2023-2028)
10.3 France
10.3.1 Historical Trend (2018-2022)
10.3.2 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Historical Trend (2018-2022)
10.4.2 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Haematology Analyser and Reagent Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2022)
11.1.2 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Historical Trend (2018-2022)
11.2.2 Forecast Trend (2023-2028)
11.3 India
11.3.1 Historical Trend (2018-2022)
11.3.2 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Historical Trend (2018-2022)
11.4.2 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Historical Trend (2018-2022)
11.5.2 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Haematology Analyser and Reagent Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2022)
12.1.2 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Historical Trend (2018-2022)
12.2.2 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Historical Trend (2018-2022)
12.3.2 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Haematology Analyser and Reagent Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2022)
13.1.2 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2022)
13.2.2 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Historical Trend (2018-2022)
13.3.2 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Historical Trend (2018-2022)
13.4.2 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Abbott Laboratories
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Beckman Coulter, Inc.
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 HORIBA Ltd
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Siemens Healthcare Private Limited
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Nihon Kohden Corporation
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Sysmex America, Inc.
16.2.6.1 Company Overview
16.2.6.2 Product Portfolio
16.2.6.3 Demographic Reach and Achievements
16.2.6.4 Certifications
16.2.7 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Haematology Analyser and Reagent Market: Key Industry Highlights, 2018 and 2028
2. Global Haematology Analyser and Reagent Historical Market: Breakup by Product (USD Million), 2018-2022
3. Global Haematology Analyser and Reagent Market Forecast: Breakup by Product (USD Million), 2023-2028
4. Global Haematology Analyser and Reagent Historical Market: Breakup by Usage Type (USD Million), 2018-2022
5. Global Haematology Analyser and Reagent Market Forecast: Breakup by Usage Type (USD Million), 2023-2028
6. Global Haematology Analyser and Reagent Historical Market: Breakup by Price Range (USD Million), 2018-2022
7. Global Haematology Analyser and Reagent Market Forecast: Breakup by Price Range (USD Million), 2023-2028
8. Global Haematology Analyser and Reagent Historical Market: Breakup by Application (USD Million), 2018-2022
9. Global Haematology Analyser and Reagent Market Forecast: Breakup by Application (USD Million), 2023-2028
10. Global Haematology Analyser and Reagent Historical Market: Breakup by End Use (USD Million), 2018-2022
11. Global Haematology Analyser and Reagent Market Forecast: Breakup by End Use (USD Million), 2023-2028
12. Global Haematology Analyser and Reagent Historical Market: Breakup by Region (USD Million), 2018-2022
13. Global Haematology Analyser and Reagent Market Forecast: Breakup by Region (USD Million), 2023-2028
14. North America Haematology Analyser and Reagent Historical Market: Breakup by Country (USD Million), 2018-2022
15. North America Haematology Analyser and Reagent Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Europe Haematology Analyser and Reagent Historical Market: Breakup by Country (USD Million), 2018-2022
17. Europe Haematology Analyser and Reagent Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Asia Pacific Haematology Analyser and Reagent Historical Market: Breakup by Country (USD Million), 2018-2022
19. Asia Pacific Haematology Analyser and Reagent Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Latin America Haematology Analyser and Reagent Historical Market: Breakup by Country (USD Million), 2018-2022
21. Latin America Haematology Analyser and Reagent Market Forecast: Breakup by Country (USD Million), 2023-2028
22. Middle East and Africa Haematology Analyser and Reagent Historical Market: Breakup by Country (USD Million), 2018-2022
23. Middle East and Africa Haematology Analyser and Reagent Market Forecast: Breakup by Country (USD Million), 2023-2028
24. Global Haematology Analyser and Reagent Market Structure
In the forecast period of 2023-2028, the market is expected to grow at a CAGR of 6%.
The major drivers of the industry, such as the rising disposable incomes, growing health consciousness, increased demand for advanced haematological technologies, growing population, and high-throughput haematological analysis requirements, are expected to aid the market growth.
The key industry trends are the application of haematological analysers and reagents in classifying COVID patients based on severity and the rising global prevalence of haematological disorders and diseases such as leukaemia.
The major regional markets include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The products in the industry include haematology, haematosis and immunohaematology, which are further broken up by type as instruments and reagents and consumables.
The industry is divided based on usage types as standalone and point-of-care.
Based on price range, the market is classified as low, mid, and high range.
The chief application segments of the products include haemorrhagic conditions, infection-related conditions, immune system-related conditions, blood cancer, and anaemia, among others.
The end use sectors in the industry are commercial service providers, hospital laboratories, and research and academic institutes, among others.
The key industry players are Abbott Laboratories, Beckman Coulter, Inc., HORIBA Ltd, Siemens Healthcare Private Limited, Nihon Kohden Corporation, and Sysmex America, Inc., among others.
The global haematological analyser and reagent market is being driven by the rapid advancements in technology and the developing healthcare facilities. Aided by the outbreak of COVID-19 and the growing prevalence of leukaemia, the market is expected to witness a healthy growth in the forecast period of 2023-2028, growing at a CAGR of 6%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The major products in the industry are haematology, haematosis, and immunohaematology, which are further broken up by type as instruments and reagents and consumables. Based on its usage types, the haematology analyser and reagent market can be segmented into standalone and point-of-care. On the basis of price, the market is broken down as low range, mid-range, and high range. Haematology analyser and reagent find application in haemorrhagic conditions, infection-related conditions, immune system-related conditions, blood cancer, anaemia, and other segments. Based on end-uses, the market can be segmented into commercial service providers, hospital laboratories, and research and academic institutes, among others. The major regional markets are North America, Europe, the Asia Pacific, Latin America and the Middle East and Africa. The key players in the above market include Abbott Laboratories, Beckman Coulter, Inc., HORIBA Ltd, Siemens Healthcare Private Limited, Nihon Kohden Corporation, and Sysmex America, Inc, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.